US Patent Issued to Siemens Healthcare Diagnostics on Sept. 22 for "Methods for detecting aberrant results caused by incomplete delivery of a polyhapten reagent in immunoassays" (Pennsylvania, Delaware Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,774, issued on Sept. 22, was assigned to Siemens Healthcare Diagnostics Inc. (Tarrytown, N.Y.).

"Methods for detecting aberrant results caused by incomplete delivery of a polyhapten reagent in immunoassays" was invented by Amy Tyler (Lincoln University, Pa.) and Tie Wei (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of detecting aberrant results caused by delivery issues for a polyhapten reagent in the context of immunoassays are disclosed."

The patent was filed on Feb. 3, 2020, under Application No. 17/594,470.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/np...